Salsalate - J & D Pharmaceuticals
Alternative Names: JD-004 - J & D PharmaceuticalsLatest Information Update: 31 Oct 2025
At a glance
- Originator J & D Pharmaceuticals
- Class Analgesics; Anti-inflammatories; Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories; Salicylates
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Yes - Progeria; Autosomal dominant polycystic kidney disease
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Burns; Osteoarthritis; Rheumatoid arthritis
- Preclinical Progeria; Traumatic brain injuries
- Research Autosomal dominant polycystic kidney disease